|Bid||12.40 x 900|
|Ask||16.06 x 1000|
|Day's Range||12.37 - 12.70|
|52 Week Range||1.10 - 12.73|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 11, 2017 - May 12, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||17.83|
ROCHESTER, Mich., Aug. 07, 2018-- OptimizeRx Corp., a leading global provider of digital health messaging for the pharmaceutical industry, reported results for the second quarter ended June 30, 2018. Quarterly ...
NEW YORK, NY / ACCESSWIRE / August 7, 2018 / OptimizeRx Corporation (NASDAQ: OPRX ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 4:30 PM Eastern Time. ...
ROCHESTER, Mich., July 17, 2018-- OptimizeRx Corp., a leading global provider of digital health messaging for the pharmaceutical industry, will hold a conference call on Tuesday, August 7, 2018 at 4:30 ...
“Joining the Nasdaq Capital Market represents another major milestone for OptimizeRx, following a number of significant events over the last few months,” said company CEO, William Febbo. This was soon followed by our first international expansion into Europe with a major partner, building upon our reach to more than half of the ambulatory patient market in the U.S.
OptimizeRx Corp. (OPRX), the nation's leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate at the ROTH London Conference being held on June 19-20, 2018 at the Dorchester Hotel in London, U.K. The ROTH London Conference will give investors extensive interaction and one-on-one/small group meetings with management teams from ~50 small/mid-cap companies in the technology, cleantech and industrial sectors, and provide in-depth insights into each of them. The event is for institutional clients of ROTH and is by invitation only.
ROCHESTER, MI / ACCESSWIRE / May 21, 2018 / OptimizeRx Corp. (OPRX), the nation's leading provider of digital health messaging for the pharmaceutical industry, has been invited to present at 8th Annual LD Micro Invitational Conference being held on June 4-6, 2018 at the Luxe Sunset Bel Air Hotel in Bel Air, California. OptimizeRx CEO William Febbo is scheduled to present on Tuesday, June 5, at 8:30 a.m. Pacific time, with one-on-one meetings held throughout the day. The LD Micro Invitational Conference is one of the nation's largest independent conferences for small/micro-cap companies, with more than 230 names presenting to 1,000+ attendees.
OTC Markets Group EVP Jason Paltrowitz to Speak on Panel on "Reg A+ Offerings" NEW YORK , March 8, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for ...
NEW YORK, NY / ACCESSWIRE / March 5 , 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of OptimizeRx Corp. (OTCQB: OPRX) and Zynex Inc. (OTCQB: ZYXI), including ...
NEW YORK, NY / ACCESSWIRE / February 27, 2018 / OptimizeRx Corporation (OTCQB: OPRX ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 4:30 PM Eastern ...